Trial Profile
Immunogenicity and safety of two doses of AS03A- adjuvanted inuenza A/H1N1 2009 vaccine (Pandemrix ®) in cancer patients on chemotherapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Jun 2017
Price :
$35
*
At a glance
- Drugs AS03A (Primary) ; Influenza A virus H1N1 vaccines (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Adverse reactions; Pharmacodynamics
- Acronyms VACANCE
- 28 Jun 2017 New trial record
- 05 Jun 2017 Results presented at the ASM Microbe 2017